343 related articles for article (PubMed ID: 24388408)
1. Pancreatoduodenectomy associated complications influence cancer recurrence and time interval to death.
van der Gaag NA; Harmsen K; Eshuis WJ; Busch ORC; van Gulik TM; Gouma DJ
Eur J Surg Oncol; 2014 May; 40(5):551-558. PubMed ID: 24388408
[TBL] [Abstract][Full Text] [Related]
2. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.
Serrano PE; Kim D; Kim PT; Greig PD; Moulton CA; Gallinger S; Wei AC; Cleary SP
Am Surg; 2016 Dec; 82(12):1187-1195. PubMed ID: 28234183
[TBL] [Abstract][Full Text] [Related]
3. Postoperative complications influence prognosis and recurrence patterns in periampullary cancer.
Cho JY; Han HS; Yoon YS; Hwang DW; Jung K; Kim YK
World J Surg; 2013 Sep; 37(9):2234-41. PubMed ID: 23722466
[TBL] [Abstract][Full Text] [Related]
4. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
[TBL] [Abstract][Full Text] [Related]
5. Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma.
Staerkle RF; Vuille-Dit-Bille RN; Soll C; Troller R; Samra J; Puhan MA; Breitenstein S
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011490. PubMed ID: 33471373
[TBL] [Abstract][Full Text] [Related]
6. Pancreaticoduodenectomy for periampullary cancer: does the tumour entity influence perioperative morbidity and long-term outcome?
Wiltberger G; Krenzien F; Atanasov G; Hau HM; Schmelzle M; Bartels M; Benzing C
Acta Chir Belg; 2018 Dec; 118(6):341-347. PubMed ID: 30203717
[TBL] [Abstract][Full Text] [Related]
7. Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer.
Tol JA; Brosens LA; van Dieren S; van Gulik TM; Busch OR; Besselink MG; Gouma DJ
Br J Surg; 2015 Feb; 102(3):237-45. PubMed ID: 25529117
[TBL] [Abstract][Full Text] [Related]
8. Recurrent disease after microscopically radical (R0) resection of periampullary adenocarcinoma in patients without adjuvant therapy.
de Castro SM; Kuhlmann KF; van Heek NT; Busch OR; Offerhaus GJ; van Gulik TM; Obertop H; Gouma DJ
J Gastrointest Surg; 2004 Nov; 8(7):775-84; discussion 784. PubMed ID: 15531230
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
10. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors.
Tran KT; Smeenk HG; van Eijck CH; Kazemier G; Hop WC; Greve JW; Terpstra OT; Zijlstra JA; Klinkert P; Jeekel H
Ann Surg; 2004 Nov; 240(5):738-45. PubMed ID: 15492552
[TBL] [Abstract][Full Text] [Related]
11. [Risk factors of postoperative complications of pancreatoduodenectomy].
He KJ; Jiao XY; Yang XW; Hu YZ
Ai Zheng; 2008 Jan; 27(1):75-7. PubMed ID: 18184469
[TBL] [Abstract][Full Text] [Related]
12. Is pancreatoduodenectomy justified for periampullary cancers with regional lymph node involvement?
Shyr YM; Su CH; Lo SS; Wang HC; Lui WY
Am Surg; 1995 Apr; 61(4):288-93. PubMed ID: 7893088
[TBL] [Abstract][Full Text] [Related]
13. Pancreaticoduodenectomy for periampullary adenocarcinoma.
Andersen HB; Baden H; Brahe NE; Burcharth F
J Am Coll Surg; 1994 Nov; 179(5):545-52. PubMed ID: 7952456
[TBL] [Abstract][Full Text] [Related]
14. Less morbidity after pancreaticoduodenectomy of patients with pancreatic cancer.
Satoi S; Takai S; Matsui Y; Terakawa N; Iwaki R; Fukui J; Yanagimoto H; Takahashi K; Toyokawa H; Araki H; Kwon AH; Kamiyama Y
Pancreas; 2006 Jul; 33(1):45-52. PubMed ID: 16804412
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer].
Roder JD; Siewert JR
Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655
[TBL] [Abstract][Full Text] [Related]
16. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
[TBL] [Abstract][Full Text] [Related]
17. Vascular resection in pancreaticoduodenectomy for periampullary cancers. A 10 year retrospective cohort study.
Podda M; Thompson J; Kulli CTG; Tait IS
Int J Surg; 2017 Mar; 39():37-44. PubMed ID: 28110027
[TBL] [Abstract][Full Text] [Related]
18. Predictors of long-term survival after pancreaticoduodenectomy for peri-ampullary adenocarcinoma: A retrospective study of 5-year survivors.
El Nakeeb A; El Sorogy M; Ezzat H; Said R; El Dosoky M; Abd El Gawad M; Elsabagh AM; El Hanafy E
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):443-449. PubMed ID: 30126828
[TBL] [Abstract][Full Text] [Related]
19. [Pancreatic cancer. Analysis of 149 cases in our 17-year experience].
Carrabetta S; De Cian F; Mondini G; Bocchio MM; D'Ambra L; Spirito C; Lazzari I; Griffanti Bartoli F; Civalleri D
G Chir; 1998; 19(6-7):265-70. PubMed ID: 9707831
[TBL] [Abstract][Full Text] [Related]
20. Reappraisal of a method of reconstruction after pancreatoduodenectomy.
Lygidakis NJ; Jain S; Sacchi M; Vrachnos P
Hepatogastroenterology; 2005; 52(64):1077-82. PubMed ID: 16001633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
